PapersPMID:32690176
The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- meta-analysis
- Population, every finding
- adults with obesity or metabolic disorders; meta-analysis of 12 RCTs
No finding here moved its endpoint.
What did not
How to read these marks →“However, berberine intake did not affect liver enzymes, including alanine aminotransferase (ALT) (WMD = -1.66 I/U, 95% CI -3.98, 0.65, P = 0.160) and aspartate aminotransferase (AST) (WMD = -0.87 I/U, 95% CI -2.56, 0.82, P = 0.311).”
- No detected effect on alanine aminotransferase
very limited
- No detected effect on aspartate aminotransferase
very limited
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Participants in randomized controlled trials of berberine reporting anthropometric parameters, CRP and liver enzymes
- Participants
- not reported
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 6
- Declined
- another reason, stated per paper
berberine